SYSTEMIC AL AMYLOIDOSIS
Clinical trials for SYSTEMIC AL AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC AL AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for SYSTEMIC AL AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tailors amyloidosis therapy based on genetic marker
Disease control Recruiting nowThis study tests a personalized approach for people with AL amyloidosis who have a specific genetic change called t(11;14). All 41 participants start with a standard three-drug combination. If their blood responds quickly within a week, they continue that treatment; if not, they …
Matched conditions: SYSTEMIC AL AMYLOIDOSIS
Phase: NA • Sponsor: Jin Lu, MD • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Blood test may predict amyloidosis treatment success in days
Knowledge-focused Recruiting nowThis study looks at whether a rapid drop in a blood marker called dFLC can predict a complete response in people with AL amyloidosis treated with daratumumab-based therapy. Researchers will follow 50 patients to see if early changes in dFLC levels match up with later treatment su…
Matched conditions: SYSTEMIC AL AMYLOIDOSIS
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC